Anton Vermond

590 total citations
16 papers, 519 citations indexed

About

Anton Vermond is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Physiology. According to data from OpenAlex, Anton Vermond has authored 16 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Anton Vermond's work include Blood properties and coagulation (13 papers), Protease and Inhibitor Mechanisms (5 papers) and Enzyme Production and Characterization (3 papers). Anton Vermond is often cited by papers focused on Blood properties and coagulation (13 papers), Protease and Inhibitor Mechanisms (5 papers) and Enzyme Production and Characterization (3 papers). Anton Vermond collaborates with scholars based in Netherlands and Slovakia. Anton Vermond's co-authors include W. Nieuwenhuizen, Jan H. Verheijen, M. Voskuilen, G T G Chang, F. Haverkate, J. Hermans, Willem J. Nooijen, J. H. VAN BOOM, Netty D. Zegers and G.H. Veeneman and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Anton Vermond

16 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Vermond Netherlands 12 332 222 193 107 80 16 519
M. Voskuilen Netherlands 15 333 1.0× 198 0.9× 219 1.1× 107 1.0× 55 0.7× 21 576
Malou Philips Denmark 12 89 0.3× 281 1.3× 295 1.5× 121 1.1× 34 0.4× 16 537
Eric-Paul Pâques Germany 8 144 0.4× 405 1.8× 360 1.9× 231 2.2× 25 0.3× 14 722
R. A. Q. O’Meara Ireland 9 101 0.3× 105 0.5× 138 0.7× 75 0.7× 52 0.7× 22 426
Stig Gustavsson 5 123 0.4× 112 0.5× 177 0.9× 71 0.7× 27 0.3× 6 402
Rosenberg Rd United States 9 86 0.3× 65 0.3× 279 1.4× 74 0.7× 13 0.2× 13 437
Laurence Vénisse France 11 56 0.2× 135 0.6× 188 1.0× 65 0.6× 7 0.1× 19 402
K Rhyner Switzerland 10 60 0.2× 28 0.1× 154 0.8× 104 1.0× 6 0.1× 47 375
Femke Noorman Netherlands 13 41 0.1× 39 0.2× 146 0.8× 105 1.0× 7 0.1× 30 585
S.F. Leitman United States 5 100 0.3× 36 0.2× 99 0.5× 118 1.1× 19 0.2× 7 616

Countries citing papers authored by Anton Vermond

Since Specialization
Citations

This map shows the geographic impact of Anton Vermond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Vermond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Vermond more than expected).

Fields of papers citing papers by Anton Vermond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Vermond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Vermond. The network helps show where Anton Vermond may publish in the future.

Co-authorship network of co-authors of Anton Vermond

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Vermond. A scholar is included among the top collaborators of Anton Vermond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Vermond. Anton Vermond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yonekawa, Osamu, Anton Vermond, & W. Nieuwenhuizen. (1990). LOCALIZATION OF A NEW SITE IN FIBRIN, INVOLVED IN THE ACCELERATION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)-CATALYZED ACTIVATION OF PLASMINOGEN. 111–116. 7 indexed citations
2.
Nieuwenhuizen, W., et al.. (1988). The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue‐type plasminogen‐activator‐mediated activation of different forms of plasminogen. European Journal of Biochemistry. 174(1). 163–169. 42 indexed citations
3.
Voskuilen, M., Anton Vermond, G.H. Veeneman, et al.. (1987). Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator.. Journal of Biological Chemistry. 262(13). 5944–5946. 75 indexed citations
4.
Pauwels, E. K. J., et al.. (1986). 99m Tc-labelled monoclonal fibrin specific antibody: Scintigraphic detection of thrombi. 25(4). 1 indexed citations
5.
Nieuwenhuizen, W., et al.. (1983). Identification of a site in fibrin(OGEN) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 748(1). 86–92. 82 indexed citations
6.
Nieuwenhuizen, W., Anton Vermond, & J. Hermans. (1983). Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrinogen). Thrombosis Research. 31(1). 81–86. 19 indexed citations
7.
Nieuwenhuizen, W., Jan H. Verheijen, Anton Vermond, & G T G Chang. (1983). Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochimica et Biophysica Acta (BBA) - General Subjects. 755(3). 531–533. 103 indexed citations
8.
Nieuwenhuizen, W., J.J. Emeis, & Anton Vermond. (1982). Catabolism of Purified Rat Fibrin(ogen) Plasmin Degradation Products in Rats. Thrombosis and Haemostasis. 48(1). 59–61. 11 indexed citations
9.
Nieuwenhuizen, W., M. Voskuilen, Anton Vermond, F. Haverkate, & J. Hermans. (1982). A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 707(2). 190–192. 26 indexed citations
10.
Nieuwenhuizen, W., J.J. Emeis, & Anton Vermond. (1982). Comparison of the in vivo clearance of des-AA and des-AABB rat fibrin monomers prepared by different methods. Biochemical and Biophysical Research Communications. 105(3). 1122–1127. 1 indexed citations
11.
Nieuwenhuizen, W., Anton Vermond, & F. Haverkate. (1981). Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin. Biochimica et Biophysica Acta (BBA) - Protein Structure. 667(2). 321–327. 16 indexed citations
12.
Nieuwenhuizen, W., Anton Vermond, & J. Hermans. (1981). Human fibrinogen binds edta and citrate. Thrombosis Research. 22(5-6). 659–663. 15 indexed citations
13.
Nieuwenhuizen, W., et al.. (1981). Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. Thrombosis Research. 22(5-6). 653–657. 35 indexed citations
14.
Nieuwenhuizen, W., et al.. (1980). Studies on the catabolism and distribution of fibrinogen in rats. Application of the iodogen® labelling technique. Biochemical and Biophysical Research Communications. 97(1). 49–55. 26 indexed citations
15.
Nieuwenhuizen, W., Anton Vermond, Willem J. Nooijen, & F. Haverkate. (1979). Calcium‐binding properties of human fibrin(ogen) and degradation products. FEBS Letters. 98(2). 257–259. 40 indexed citations
16.
Reman, F.C. & Anton Vermond. (1978). The quantitative determination of apolipoprotein A-I (apo-lp-Gln I) in human serum by radial immunodiffusion assay (RID). Clinica Chimica Acta. 87(3). 387–394. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Voskuilen Breakdown of academic impact, for papers by Malou Philips Breakdown of academic impact, for papers by Eric-Paul Pâques Breakdown of academic impact, for papers by R. A. Q. O’Meara Breakdown of academic impact, for papers by Stig Gustavsson Breakdown of academic impact, for papers by Rosenberg Rd Breakdown of academic impact, for papers by Laurence Vénisse Breakdown of academic impact, for papers by K Rhyner Breakdown of academic impact, for papers by Femke Noorman Breakdown of academic impact, for papers by S.F. Leitman
Rankless by CCL
2026